🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this trial is to evaluate the immunogenicity, the safety and...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-06-05
Trial ID
NCT02106390
Treatments Being Tested
The purpose of this study was to assess the safety, effectiveness, and immu...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-06-14
Trial ID
NCT04886154
The purpose/aim of this study is to assess the safety and antibody response...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-12-08
Trial ID
NCT02986854
The bacterium (germ) Neisseria meningitidis causes meningitis and blood poi...
Status
Completed
Location
Oxford Vaccine Group
Start Date
2012-12
Trial ID
NCT01593514
Treatments Being Tested
A phase 2/3 study to determine the efficacy, safety and immunogenicity of t...
Status
Completed
Location
University Hospital Southampton NHS Foundation Trust
Start Date
2020-05-28
Trial ID
NCT04400838
Treatments Being Tested
This study is to confirm non-inferiority of the three MenACWY vaccines (Men...
Status
Completed
Location
Children's Hospital Research Institute, University of Calgary
Start Date
2018-09-20
Trial ID
NCT03694405
Treatments Being Tested
To evaluate the safety and immune response of Novartis MenACWY conjugate va...
Status
Completed
Location
Children's Investigational Reserach Program
Start Date
2008-03
Trial ID
NCT00616421
Treatments Being Tested
MenACWY (Menveo) is a GSK vaccine intended for protection against disease c...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-08-30
Trial ID
NCT03433482
Treatments Being Tested
The purpose of the study is to evaluate and compare the immune response to ...
Status
Completed
Location
University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine
Start Date
2009-06
Trial ID
NCT00901940
The purpose of the current study is to evaluate whether there is immune int...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-07-09
Trial ID
NCT03587207
Treatments Being Tested